Barak Rotblat

4.3k total citations
57 papers, 2.4k citations indexed

About

Barak Rotblat is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Barak Rotblat has authored 57 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Barak Rotblat's work include PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Barak Rotblat is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Barak Rotblat collaborates with scholars based in Israel, Germany and Canada. Barak Rotblat's co-authors include Yoel Kloog, Gabriel Leprivier, John F. Hancock, Gerry Melino, Sarah J. Plowman, Yoav I. Henis, Richard A. Knight, Roni Haklai, Poul H. Sorensen and Ian A. Prior and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Barak Rotblat

55 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barak Rotblat Israel 28 1.8k 457 400 381 363 57 2.4k
Isabel Sánchez‐Pérez Spain 26 1.6k 0.9× 331 0.7× 473 1.2× 234 0.6× 573 1.6× 52 2.3k
Caretha L. Creasy United States 27 2.8k 1.5× 716 1.6× 317 0.8× 257 0.7× 453 1.2× 41 3.4k
Tania Maffucci United Kingdom 27 1.8k 0.9× 723 1.6× 222 0.6× 193 0.5× 321 0.9× 52 2.6k
Kam C. Yeung United States 31 3.0k 1.6× 279 0.6× 453 1.1× 324 0.9× 644 1.8× 52 3.8k
Débora Bonenfant Switzerland 15 2.1k 1.1× 300 0.7× 164 0.4× 207 0.5× 291 0.8× 19 2.6k
Jiing‐Dwan Lee United States 21 2.1k 1.1× 450 1.0× 303 0.8× 230 0.6× 472 1.3× 26 2.7k
Pat P. Ongusaha United States 17 1.5k 0.8× 241 0.5× 279 0.7× 337 0.9× 313 0.9× 20 2.0k
Maria-Magdalena Georgescu United States 17 1.8k 0.9× 339 0.7× 237 0.6× 495 1.3× 339 0.9× 29 2.5k
Sean R. Hackett United States 10 1.6k 0.9× 381 0.8× 849 2.1× 213 0.6× 537 1.5× 13 2.4k
Irene Faenza Italy 33 2.4k 1.3× 679 1.5× 411 1.0× 305 0.8× 285 0.8× 112 3.1k

Countries citing papers authored by Barak Rotblat

Since Specialization
Citations

This map shows the geographic impact of Barak Rotblat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barak Rotblat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barak Rotblat more than expected).

Fields of papers citing papers by Barak Rotblat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barak Rotblat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barak Rotblat. The network helps show where Barak Rotblat may publish in the future.

Co-authorship network of co-authors of Barak Rotblat

This figure shows the co-authorship network connecting the top 25 collaborators of Barak Rotblat. A scholar is included among the top collaborators of Barak Rotblat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barak Rotblat. Barak Rotblat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sklarz, Menachem Y., Ehud Ohana, Idan Cohen, et al.. (2025). Pharmacological activation of SIRT6 suppresses progression of head and neck and esophageal squamous cell carcinoma by modulation of cellular metabolism and protein translation. Cell Death and Disease. 16(1). 727–727. 1 indexed citations
2.
Rotblat, Barak, et al.. (2024). Enhancing Mechanical Stimulated Brillouin Scattering Imaging with Physics‐Driven Model Selection. Laser & Photonics Review. 18(6). 4 indexed citations
3.
4.
5.
Picard, Daniel, Martin F. Orth, Marc Remke, et al.. (2022). EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma. Cell Death Discovery. 8(1). 157–157. 6 indexed citations
6.
Picard, Daniel, Julian Musa, Marc Remke, et al.. (2022). Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation. Cell Death Discovery. 8(1). 91–91. 10 indexed citations
7.
Halpérin, Daniel, Rotem Kadir, Ohad Wormser, et al.. (2021). CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and mice. Nature Communications. 12(1). 6187–6187. 23 indexed citations
8.
Smirnov, Dmitri, et al.. (2021). TP73-AS1 is induced by YY1 during TMZ treatment and highly expressed in the aging brain. Aging. 13(11). 14843–14861. 6 indexed citations
9.
Levin, Liron, Daniel Picard, Ulvi Ahmadov, et al.. (2019). The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells. Cell Death and Disease. 10(3). 246–246. 133 indexed citations
10.
Tognon, Cristina E., Bo Rafn, Naniye Mallı Cetinbas, et al.. (2018). Insulin-like growth factor 1 receptor stabilizes the ETV6–NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation. Journal of Biological Chemistry. 293(32). 12502–12515. 13 indexed citations
11.
Halpérin, Daniel, Rotem Kadir, Yonatan Perez, et al.. (2018). SEC31A mutation affects ER homeostasis, causing a neurological syndrome. Journal of Medical Genetics. 56(3). 139–148. 27 indexed citations
12.
Marini, Alberto, Barak Rotblat, Thomas Sbarrato, et al.. (2018). TAp73 contributes to the oxidative stress response by regulating protein synthesis. Proceedings of the National Academy of Sciences. 115(24). 6219–6224. 27 indexed citations
13.
Zorea, Jonathan, Manu Prasad, Limor Cohen, et al.. (2018). IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer. Cell Death and Disease. 9(10). 944–944. 37 indexed citations
14.
Musa, Julian, Martin F. Orth, Marlene Dallmayer, et al.. (2016). Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis. Oncogene. 35(36). 4675–4688. 127 indexed citations
15.
Leprivier, Gabriel, Barak Rotblat, Debjit Khan, Eric Jan, & Poul H. Sorensen. (2014). Stress-mediated translational control in cancer cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1849(7). 845–860. 98 indexed citations
16.
Rotblat, Barak, Gabriel Leprivier, & Poul H. Sorensen. (2011). A possible role for long non-coding RNA in modulating signaling pathways. Medical Hypotheses. 77(6). 962–965. 13 indexed citations
17.
Rotblat, Barak, Liang Hong, Roni Haklai, et al.. (2010). H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output. PLoS ONE. 5(8). e11991–e11991. 33 indexed citations
18.
Rechavi, Oded, Itamar Goldstein, Helly Vernitsky, Barak Rotblat, & Yoel Kloog. (2007). Intercellular Transfer of Oncogenic H-Ras at the Immunological Synapse. PLoS ONE. 2(11). e1204–e1204. 35 indexed citations
19.
Rotblat, Barak, Ofer Yizhar, Roni Haklai, Uri Ashery, & Yoel Kloog. (2006). Ras and Its Signals Diffuse through the Cell on Randomly Moving Nanoparticles. Cancer Research. 66(4). 1974–1981. 32 indexed citations
20.
Henis, Yoav I., Barak Rotblat, & Yoel Kloog. (2006). FRAP beam-size analysis to measure palmitoylation-dependent membrane association dynamics and microdomain partitioning of Ras proteins. Methods. 40(2). 183–190. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Sánchez‐Pérez Breakdown of academic impact, for papers by Caretha L. Creasy Breakdown of academic impact, for papers by Tania Maffucci Breakdown of academic impact, for papers by Kam C. Yeung Breakdown of academic impact, for papers by Débora Bonenfant Breakdown of academic impact, for papers by Jiing‐Dwan Lee Breakdown of academic impact, for papers by Pat P. Ongusaha Breakdown of academic impact, for papers by Maria-Magdalena Georgescu Breakdown of academic impact, for papers by Sean R. Hackett Breakdown of academic impact, for papers by Irene Faenza
Rankless by CCL
2026